Peru has declared a state of emergency as it experiences a surge in cases of Guillain-Barre syndrome (GBS), a rare autoimmune disease. With nearly 200 reported instances in recent months, the Peruvian government has allocated over $3 million to procure drugs for treatment and provide necessary support for affected individuals.
On Saturday, Peruvian Health Minister Cesar Vasquez announced the 90-day state of emergency during a visit to the National Institute of Neurological Sciences. Vasquez emphasized the need to take immediate action to protect the health and lives of the people as the number of GBS cases continues to rise.
The state of emergency declaration will enable the National Center for the Supply of Strategic Health Resources to purchase immunoglobulin, a treatment for GBS patients, for the next two years. The government has allocated over 12 million Peruvian sol ($3.3 million) towards this effort. While most regions already have sufficient medicines, a redistribution scheme has been established to provide support to areas with a greater need.
According to official data, Peru has recorded a total of 182 GBS cases to date. Out of these cases, 31 patients are still hospitalized, while 147 have been discharged. Unfortunately, four individuals have lost their lives to the disease since the start of the year.
Guillain-Barre syndrome is a rare condition characterized by the immune system attacking the peripheral nerves. This attack leads to temporary loss of muscle control and an inability to sense pain, temperature, or touch. While most patients recover fully without complications, there are severe cases where the disease can be life-threatening. When the chest muscles are affected, breathing becomes difficult, and patients may also experience difficulty speaking or swallowing. In such instances, patients require constant monitoring in intensive care units.
GBS can be triggered by bacterial or viral infections, as well as vaccine administration or surgery. It is particularly prevalent in patients infected with the Zika virus. The World Health Organization states that on average, 3%-5% of GBS sufferers die from complications of the disease.
There is currently no cure for Guillain-Barre syndrome. Treatment focuses on managing symptoms and shortening the duration of the condition. Medical professionals provide supportive care to alleviate discomfort and assist with the recovery process.
Peru’s state of emergency declaration reflects the government’s commitment to addressing the growing GBS crisis and ensuring the provision of necessary resources and support to affected individuals. Authorities continue to monitor the situation closely and work towards the effective management and control of the disease within the country.
Source link
